These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26264279)

  • 21. A synthetic polyvalent ligand for α5β1 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guérin.
    Chen F; Zhang G; Cao Y; Wakim B; See WA
    J Urol; 2013 Mar; 189(3):1104-9. PubMed ID: 22999999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer.
    Ide H; Inoue S; Mizushima T; Jiang G; Chuang KH; Oya M; Miyamoto H
    Mol Cancer Ther; 2018 Jul; 17(7):1566-1574. PubMed ID: 29720561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravesical treatment of chemotherapeutic agents sensitizes bacillus Calmette‑Guerin by the modulation of the tumor immune environment.
    Hori S; Miyake M; Tatsumi Y; Morizawa Y; Nakai Y; Onishi S; Onishi K; Iida K; Gotoh D; Itami Y; Tanaka N; Fujimoto K
    Oncol Rep; 2019 Mar; 41(3):1863-1874. PubMed ID: 30628699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
    Ping SY; Wu CL; Yu DS
    Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of androgen receptor degradation enhancer ASC-J9(®) in mouse sera and organs with liquid chromatography tandem mass spectrometry.
    Soh SF; Huang CK; Lee SO; Xu D; Yeh S; Li J; Yong EL; Gong Y; Chang C
    J Pharm Biomed Anal; 2014 Jan; 88():117-22. PubMed ID: 24042123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ASC-J9 for castration-resistant prostate cancer].
    Yamashita S; Arai Y
    Nihon Rinsho; 2014 Dec; 72(12):2126-9. PubMed ID: 25518345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.
    Garcia PV; Apolinário LM; Böckelmann PK; da Silva Nunes I; Duran N; Fávaro WJ
    Int J Clin Exp Pathol; 2015; 8(5):4427-43. PubMed ID: 26191134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
    Imada S; Akaza H; Ami Y; Koiso K; Ideyama Y; Takenaka T
    Eur Urol; 1997; 31(3):360-4. PubMed ID: 9129932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin.
    Zhang G; Chen F; Cao Y; Amos JV; Shah G; See WA
    J Urol; 2013 Sep; 190(3):1076-82. PubMed ID: 23353043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
    Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
    Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals.
    Lin SJ; Chou FJ; Lin CY; Chang HC; Yeh S; Chang C
    Oncotarget; 2016 Oct; 7(41):66769-66775. PubMed ID: 27564257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additive antitumor effect of arsenic trioxide combined with intravesical bacillus Calmette-Guerin immunotherapy against bladder cancer through blockade of the IER3/Nrf2 pathway.
    Mao MH; Huang HB; Zhang XL; Li K; Liu YL; Wang P
    Biomed Pharmacother; 2018 Nov; 107():1093-1103. PubMed ID: 30257321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo.
    Jinesh GG; Lee EK; Tran J; Kamat AM
    Urol Oncol; 2013 Nov; 31(8):1676-1682. PubMed ID: 22717623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.
    Yang Z; Chang YJ; Yu IC; Yeh S; Wu CC; Miyamoto H; Merry DE; Sobue G; Chen LM; Chang SS; Chang C
    Nat Med; 2007 Mar; 13(3):348-53. PubMed ID: 17334372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor.
    Cai Y; Lee YF; Li G; Liu S; Bao BY; Huang J; Hsu CL; Chang C
    Int J Cancer; 2008 Jul; 123(1):195-201. PubMed ID: 18386814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway.
    He D; Li L; Zhu G; Liang L; Guan Z; Chang L; Chen Y; Yeh S; Chang C
    Cancer Res; 2014 Aug; 74(16):4420-30. PubMed ID: 24924778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.
    Zhang G; Chen F; Cao Y; See WA
    Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
    Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.